Mechanistically, especially T cell-derived type II interferon, IFNγ, has been identified to directly interfere with intestinal epithelial cell homeostasis as it negatively regulates intestinal stem cell maintenance and recovery in the course of intestinal GvHD (5). Here, IFNG is linked to graft versus host disease.